Omada Health, Inc. (NASDAQ:OMDA) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) have earned an average rating of "Moderate Buy" from the thirteen ratings firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating a
Shares of Omada Health, Inc. (NASDAQ:OMDA-Get Free Report) have earned an average rating of "Moderate Buy" from the thirteen ratings firms that are covering the stock,MarketBeat Ratingsreports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and ten have assigned a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $22. 9091. Several brokerages have recently commented on OMDA. Wells Fargo & Company upped their price objective on shares of Omada Health from $17. 00 to $18. 00 and gave the stock an "equal weight" rating in a report on Friday, May 8th. Canaccord Genuity Group set a $24. 00 price target on Omada Health in a research note on Friday, May 8th. The Goldman Sachs Group restated a "buy" rating on shares of Omada Health in a research report on Friday, May 8th. Weiss Ratingsraised Omada Health from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, June 26th. Finally, Morgan Stanley reissued an "overweight" rating and set a $30. 00 target price on shares of Omada Health in a research note on Monday, June 22nd. GetOmada Healthalerts:Read Our Latest Stock Analysis on OMDAOmada Health Stock Down 1. 1%Shares ofOmada Health stocktraded down $0. 27 during trading hours on Friday, reaching $23. 28. 733,822 shares of the company's stock were exchanged, compared to its average volume of 1,074,948. Omada Health has a 1 year low of $10. 28 and a 1 year high of $26. 92. The company has a market capitalization of $1. 38 billion and a P/E ratio of -86. 22. The business has a fifty day moving average of $18. 19 and a two-hundred day moving average of $15. 39. Omada Health (NASDAQ:OMDA-Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0. 05) EPS for the quarter, topping the consensus estimate of ($0. 08) by $0. 03. Omada Health had a negative return on equity of 1. 82% and a negative net margin of 2. 22%. The business had revenue of $78. 05 million for the quarter. As a group, research analysts predict that Omada Health will post -0. 01 EPS for the current year. Insider Activity at Omada HealthIn other news, CAO Craig Gracey sold 6,894 shares of Omada Health stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $17. 42, for a total value of $120,093. 48. Following the completion of the transaction, the chief accounting officer owned 9,191 shares in the company, valued at approximately $160,107. 22. This trade represents a 42. 86% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed throughthe SEC website. Also, CFOSteven L. Cooksold 33,000 shares of Omada Health stock in a transaction on Friday, June 26th. The stock was sold at an average price of $19. 89, for a total transaction of $656,370. 00. Following the sale, the chief financial officer directly owned 133,359 shares of the company's stock, valued at approximately $2,652,510. 51. This trade represents a 19. 84% decrease in their ownership of the stock. Additional details regarding this sale are available in theofficial SEC disclosure. Over the last three months, insiders sold 193,462 shares of company stock worth $3,927,425. Company insiders own 6. 38% of the company's stock. Institutional Inflows and OutflowsHedge funds have recently added to or reduced their stakes in the company. Quarry LP purchased a new position in Omada Health in the 4th quarter valued at $29,000. TD Waterhouse Canada Inc. acquired a new stake in shares of Omada Health in the 4th quarter worth $32,000. Raymond James Financial Inc. purchased a new stake in shares of Omada Health in the second quarter valued at about $32,000. Inlight Wealth Management LLC acquired a new position in shares of Omada Health during the fourth quarter worth about $45,000. Finally, Versant Capital Management Inc increased its stake in shares of Omada Health by 319. 3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock worth $66,000 after acquiring an additional 2,283 shares during the period. Omada Health Company Profile(Get Free Report)Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching. In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management. Featured StoriesFive stocks we like better than Omada Health3 Rare-Earth ETFs That Help Investors Balance Exposure and RiskMicrosoft Bets on In-House AI to Cut OpenAI and Anthropic CostsDelta Air Lines Lives Up to Its Claims: Shares Can Keep ClimbingThis Dividend ETF Choice Could Shape Your Income Strategy Through 2026This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Should You Invest $1,000 in Omada Health Right Now?Before you consider Omada Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Omada Health wasn't on the list. While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list. Get This Free Report